Drugs & medicalClass III

Aadi Bioscience recalls Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for…

Failed Stability Specifications

Read the official notice →
Date
2022-11-23
Country
United States
Brand
Aadi Bioscience
Product
Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for…
Classification
Class III
Units
Within the U.S Market - PA, AL, KY, TN
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2022-11-23
  2. US
    Drugs & medicalClass II

    ICU Medical Inc recalls 0.9% Sodium Chloride Injection, USP, 100 mL flexible container bag, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC…

    Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.

    FDA · DrugICU Medical IncNationwide in the USAOfficial notice →
  3. US
    Drugs & medicalClass II

    Par Formulations Private Limited recalls Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY…

    Failed Impurities/Degradation Specifications

    FDA · DrugPar Formulations Private LimitedNationwide within the United StatesOfficial notice →
  4. US
    Drugs & medicalClass II

    ImprimisRx NJ recalls Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.

    Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.

    FDA · DrugImprimisRx NJNationwide in the USAOfficial notice →
  5. 2022-11-16
  6. US
    Drugs & medicalClass II

    Boston Scientific Corporation recalls ORISE Gel Submucosal Lifting Agent--Indicated for use in gastrointestinal endoscopic procedures for submucosal lift of polyps,…

    ***Update12/13/22***:Product removal due to higher incidence of adverse events of foreign body reactions*** Potential outcomes associated with foreign body reaction to remnant ORlSE Gel post procedure. Foreign body…

    FDA · DeviceBoston Scientific CorporationWorldwide Distribution: US (Nationwide) and (Foreign) countries of: Algeria…Official notice →
  7. US
    Drugs & medicalClass II

    CooperSurgical, Inc. recalls NEO-fit Neonatal Endotracheal Tube Grip, Part Number 42-2540

    Firm has received 11 complaints involving a loose or detached metal clips, including 3 cases where the metal clip was ingested by the patient, and 3 cases where the metal clip was removed from the patient's mouth. In…

    FDA · DeviceCooperSurgical, Inc.Worldwide distribution: US (Nationwide) including Puerto Rico; and countries…Official notice →
  8. US
    Drugs & medicalClass II

    X-NAV Technologies, LLC recalls X-Guide X-Mark Probe Tool -used for registering edentulous patients to the software or performing XMark registration. Catalog…

    Product missing one of two welds connecting the tip to the shaft, if the remaining weld breaks, it is possible that the tip could fall out during X-Mark registration and fall into the patient s mouth. In this case, the…

    FDA · DeviceX-NAV Technologies, LLCUS Nationwide distribution and Foreign country of: CanadaOfficial notice →
See all drugs & medical recalls →